Sitagliptin Phosphate Monohydrate APIs are pivotal in the portfolio of Loncom Pharma, catering to the therapeutic area of diabetes. They are used in oral antihyperglycemic medications that regulate insulin levels and lower blood sugar.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
